BIN2 antibody (AA 290-496)
-
- Target See all BIN2 Antibodies
- BIN2 (Bridging Integrator 2 (BIN2))
-
Binding Specificity
- AA 290-496
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This BIN2 antibody is un-conjugated
-
Application
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Cross-Reactivity
- Human
- Purification
- >95%, Protein G purified
- Immunogen
- Recombinant Human Bridging integrator 2 protein (290-496AA)
- Isotype
- IgG
-
-
- Application Notes
- Recommended dilution: IHC:1:20-1:200, IF:1:20-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C,-80 °C
- Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- BIN2 (Bridging Integrator 2 (BIN2))
- Alternative Name
- BIN2 (BIN2 Products)
- Synonyms
- BRAP-1 antibody, BIN2 antibody, bin2l antibody, wu:fi05e01 antibody, zgc:55758 antibody, bridging integrator 2 antibody, bridging integrator 2b antibody, BIN2 antibody, Bin2 antibody, bin2b antibody
- Background
-
Background: Promotes cell motility and migration, probably via its interaction with the cell membrane and with podosome proteins that mediate interaction with the cytoskeleton. Modulates membrane curvature and mediates membrane tubulation. Plays a role in podosome formation. Inhibits phagocytosis.
Aliases: BIN2 antibody, BRAP1Bridging integrator 2 antibody, Breast cancer-associated protein 1 antibody
- UniProt
- Q9UBW5
-